Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Ayala Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2024 | $7.3K | $7.3K - $7.3K | -$7.3K | -$12.00 | 1 |
| Dec 2023 | $13.0K | $13.0K - $13.0K | -$13.0K | -$5.97 | 1 |
| Dec 2022 | $2.00M | $2.00M - $2.00M | -$2.00M | -$2.58 | 1 |
| Dec 2021 | $2.99M | $2.99M - $2.99M | -$2.99M | -$16.00 | 1 |
| Dec 2020 | $3.0K | $3.0K - $3.0K | -$3.0K | -$48.00 | 1 |
| Dec 2019 | $21.00M | $21.00M - $21.00M | -$12.55M | -$189.60 | 1 |
| Dec 2018 | $6.27M | $6.27M - $6.27M | -$6.27M | -$1,308.00 | 1 |
| Dec 2017 | $12.36M | $12.36M - $12.36M | -$80.26M | -$2,673.00 | 1 |
| Dec 2016 | $325.0K | $325.0K - $325.0K | -$325.0K | -$2,466.00 | 1 |